Epilepsy trials in Georgia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  An Open-label Study of XEN1101 in Epilepsy

  Where

  Tbilisi

  Age

  12 years and over

  People

  880 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05718817 · EU 2022-502282-24-00
• Phase 3Taking people
  A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

  Where

  Tbilisi

  Age

  2 years and over

  People

  150 worldwide

  Run by

  Epygenix

  See details and how to joinNCT04462770 · EU 2024-518628-57-00